Mitzi Nagarkatti to Endocannabinoids
This is a "connection" page, showing publications Mitzi Nagarkatti has written about Endocannabinoids.
Connection Strength
2.765
-
Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis. Cells. 2021 11 25; 10(12).
Score: 0.770
-
Production of endocannabinoids by activated T?cells and B?cells modulates inflammation associated with delayed-type hypersensitivity. Eur J Immunol. 2016 06; 46(6):1472-9.
Score: 0.526
-
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease. Int Rev Immunol. 2015; 34(5):403-14.
Score: 0.459
-
Anandamide attenuates Th-17 cell-mediated delayed-type hypersensitivity response by triggering IL-10 production and consequent microRNA induction. PLoS One. 2014; 9(4):e93954.
Score: 0.453
-
Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1. J Leukoc Biol. 2014 Apr; 95(4):609-19.
Score: 0.443
-
Endocannabinoids and immune regulation. Pharmacol Res. 2009 Aug; 60(2):85-92.
Score: 0.080
-
Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. Mol Pharmacol. 2008 Jul; 74(1):20-33.
Score: 0.019
-
Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation. J Immunol. 2004 Aug 15; 173(4):2373-82.
Score: 0.015